Not applicableStudy completedNCT00871520What this trial is testingPrognosis and Survival Estimates in Palliative TherapyWho this might be right forCancer Heinrich-Heine University, Duesseldorf 612
Testing effectiveness (Phase 2)Study completedNCT00004923What this trial is testingDocetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Yale University 47
Testing effectiveness (Phase 2)Looking for participantsNCT06712680What this trial is testingA Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver GenesWho this might be right forSolid Tumor Sichuan Huiyu Pharmaceutical Co., Ltd 115
Testing effectiveness (Phase 2)Looking for participantsNCT06125080What this trial is testingThe Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical StudyWho this might be right forTNBC - Triple-Negative Breast Cancer Huihua Xiong 78
Not applicableUnknownNCT03936179What this trial is testingHigh Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal CancerWho this might be right forEsophageal Cancer Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308What this trial is testingImlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasm Metastasis Eli Lilly and Company 874
Testing effectiveness (Phase 2)UnknownNCT05350917What this trial is testingStudy of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard TherapyWho this might be right forHER2-positive or Mutated Advanced Colorectal Cancer The First Affiliated Hospital of Zhengzhou University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06992258What this trial is testingPhase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerWho this might be right forColorectal Cancer Criterium, Inc. 120
Not applicableUnknownNCT05051358What this trial is testingTherapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry StudyWho this might be right forTherapeutic Endoscopic UltrasoundAdvanced EndoscopyTherapeutic Endoscopy+11 more Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University 5,000
Not applicableLooking for participantsNCT07126678What this trial is testingFixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular LymphomaWho this might be right forFollicular LymphomaTreatment Naive The First Affiliated Hospital with Nanjing Medical University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06868485What this trial is testingAssess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Wayshine Biopharm, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT02396108What this trial is testingDose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast CancerWho this might be right forBreast Cancer National University Hospital, Singapore 55
Testing effectiveness (Phase 2)Study completedNCT00003276What this trial is testingIrinotecan in Treating Patients With Advanced Gallbladder or Bile Duct CancerWho this might be right forGallbladder Cancer Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Study completedNCT05708950What this trial is testingA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)Who this might be right forCancerSolid TumorMelanoma+14 more Kineta Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07818018What this trial is testing2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction AdenocarcinomaWho this might be right forEsophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06788197What this trial is testingSHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer PatientsWho this might be right forBreast CancerLocally Advanced or Metastatic Breast Cancer Henan Cancer Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT07789210What this trial is testingA Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable MetastasesWho this might be right forColorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more Zhejiang University 25
Not applicableLooking for participantsNCT07584824What this trial is testingIs the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?Who this might be right forCancerCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Solid Tumors)+2 more Royal Cornwall Hospitals Trust 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07257380What this trial is testingFeasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)Who this might be right forGastric / Gastroesophageal Junction Adenocarcinoma Shanghai Zhongshan Hospital 90
Early research (Phase 1)Study completedNCT01928459What this trial is testingPhase 1b Trial of BGJ398/BYL719 in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Novartis Pharmaceuticals 62